a public good project by the
Synthesis
Company
of California

© 2026

Antipsychotic polypharmacy does not increase the risk for side effects | doi.page

0 citations

Google Scholar doi.org

Antipsychotic polypharmacy does not increase the risk for side effects

Schizophrenia Research·2007·Vol. 98(1-3), pp. 323–324

Citations Over TimeTop 24% of 2007 papers

Soma Ganesan, Ross Taylor, Ian T. Forbes, Kiran Rabheru, Jane Dumontet, Ric M. Procyshyn

Related Papers

→ The evolution of antipsychotic switch and polypharmacy in natural practice — A longitudinal perspective(2011)66 cited
→ Frequency, reasons, and factors associated with antipsychotic polypharmacy in Schizophrenia: A retrospective chart review in a tertiary hospital in India(2020)13 cited
→ Attitudes towards and rationale for antipsychotic polypharmacy among psychiatrists in Nigeria: Characteristics associated with high reported antipsychotic polypharmacy(2016)11 cited
→ Antipsychotic Medication Prescribing Practices Among Adult Patients Discharged From State Psychiatric Inpatient Hospitals(2016)7 cited
Causes of antipsychotic polypharmacy in schizophrenia treatment(2009)